Diagnostic Approach to Abdominal Masses
Initial Evaluation and Imaging
- The National Comprehensive Cancer Network recommends laboratory workup including CA-125, AFP, beta-hCG (in women <35 years), inhibin, and CEA for pelvic/adnexal masses 1, 2
- For suspected mucinous histology, the National Comprehensive Cancer Network suggests performing gastrointestinal tract evaluation to rule out metastatic disease from GI primary 2
- The National Comprehensive Cancer Network recommends CT chest, abdomen, and pelvis for retroperitoneal/mediastinal masses, along with laboratory tests such as beta-hCG and AFP 3
Tissue Diagnosis and Biopsy
- The European Society for Medical Oncology recommends image-guided core needle biopsy for solid masses >2 cm, via endoscopic ultrasound or CT/ultrasound-guided percutaneous approach 4
- The National Comprehensive Cancer Network advises against fine-needle aspiration for suspected ovarian masses to prevent spillage of malignant cells into the peritoneal cavity 1
Essential Laboratory Workup and Additional Testing
- The National Comprehensive Cancer Network recommends fecal occult blood testing as part of the standard laboratory workup for all patients 5
- For men >40 years, the National Comprehensive Cancer Network suggests PSA testing, except if metastases are limited to liver or brain 3
- For women <35 years with pelvic mass, the National Comprehensive Cancer Network recommends AFP and beta-hCG testing to assess for germ cell tumors and rule out pregnancy 2
- The National Comprehensive Cancer Network advises bone scan and radiographic studies for bone involvement, and urine cytology followed by cystoscopy if suspicious for retroperitoneal mass 3
Additional Imaging Considerations
- The National Comprehensive Cancer Network recommends chest imaging before surgical staging to evaluate for metastases 1
- The National Comprehensive Cancer Network suggests upper/lower endoscopy if symptoms suggest gastrointestinal or visceral involvement 5
- The National Comprehensive Cancer Network advises considering PET/CT scan for unexplained lymphadenopathy, visceral masses, or bone lesions 5
Initial Workup for Abdominal Mass
Initial Evaluation
- The American College of Radiology recommends ultrasound as the first-line imaging modality for all abdominal masses, followed by CT or MRI based on the suspected diagnosis and location of the mass 6, 7, 8
- Location, duration, and progression of the mass should be assessed, along with associated symptoms such as jaundice, weight loss, abdominal pain, nausea, vomiting, and fever 7
- Risk factors for specific conditions, including age, gender, and family history, should be considered 9, 10
Imaging Algorithm
- Ultrasound is the preferred initial imaging modality for abdominal masses, helping to determine if the mass is solid or cystic, and assessing vascularity and relationship to surrounding structures 6, 7, 8, 11
- CT abdomen and pelvis with IV contrast is the preferred modality for suspected malignancy or indeterminate ultrasound findings, providing detailed characterization of the mass and assessment for metastasis 8, 12
- MRI pelvis without and with IV contrast is recommended for suspected adnexal/pelvic mass if ultrasound is indeterminate, superior for characterizing complex adnexal masses 11, 13
Diagnostic Approach by Location
- For pelvic/adnexal masses, initial imaging should include transvaginal and transabdominal ultrasound with Doppler, and laboratory tests such as CA-125, AFP, and hCG (age-dependent) 14, 15, 11, 13
- For upper abdominal masses, initial imaging should include abdominal ultrasound, and laboratory tests such as liver function tests and tumor markers based on suspected origin 7, 14, 12
- For pulsatile abdominal masses, initial imaging should include abdominal ultrasound with Doppler, and CT angiography if confirmed or suspected AAA 6, 8
Biopsy Considerations
- Image-guided core needle biopsy is preferred for suspicious solid masses, and fine-needle aspiration should be avoided for suspected ovarian masses to prevent spillage of malignant cells 10, 12
- Biopsy tract should be planned so it can be removed during definitive surgery if malignancy is confirmed 12